CB 300919 is a quinazoline-based antitumour agent with high activity in the CH1 human ovarian tumour xenograft. CB 300919 has a continuous exposure (96 h) growth inhibition IC 50 value of 2 nM in human CH1 ovarian tumor xenograft. Form:Solid
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
CB 300919
CAS number:289715-28-2 molecular formula:C32H34ClN7O2
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | SCHEMBL6584545 | Benzamide, 4-(((7-chloro-3,4-dihydro-3-methyl-2-((4-methyl-1-piperazinyl)methyl)-4-oxo-6-quinazolinyl)methyl)-2-propynylamino)-N-(3-pyridinylmethyl)- | A924598 | 55I8ETE76Y | MS-30457 | CB 300919 | Benzamide, 4-(((7-chloro-3,4-dihydro-3-m | ||
| CAS number | 289715-28-2 | molecular formula | C32H34ClN7O2 |
| molecular weight | 584.11 g/mol | Exact mass | ≥98% |
| PSA | 84.400 Ų | logp | 2.800 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





